WO0119829A3
Pyrazolopyrimidines as therapeutic agents
Abstract
The present invention provides compounds of Formula (I), including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, R3 are defined as described herein and their use as protein Kinase inhibitors.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US5593997A | Cites | United States of America | A | International search | 1,35 |
| WO9631510A1 | Cites | World Intellectual Property Organization (WIPO) | A | International search | 1,35 |
60 members in 32 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 15462099 | United States of America | P | |
| 15462099 | United States of America | P | |
| 60154620 | – | – | – |
| US19990154620P | – | – | – |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| CA2385747A1 | Canada | A1 | |
| WO0119829A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7495000A | Australia | A | |
| WO0119829A3This record | World Intellectual Property Organization (WIPO) | A3 | |
| NO20021328D0 | Norway | D0 | |
| NO20021328L | Norway | L | |
| EP1212327A2 | European Patent Office (EPO) | A2 | |
| BR0014073A | Brazil | A | |
| IL148718D0 | Israel | D0 | |
| CZ2002936A3 | Czechia | A3 | |
| CA2440724A1 | Canada | A1 | |
| WO02080926A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2002156081A1 | United States of America | A1 | |
| PE20020967A1 | Peru | A1 | |
| UY27226A1 | Uruguay | A1 | |
| KR20020088406A | Republic of Korea | A | |
| CN1390219A | China | A | |
| TR200201505T2 | Türkiye | T2 | |
| BG106586A | Bulgaria | A | |
| JP2003509428A | Japan | A | |
| HK1050355A1 | Hong Kong, China | A1 | |
| EP1212327B1 | European Patent Office (EPO) | B1 | |
| ZA200202123B | South Africa | B | |
| SK3812002A3 | Slovakia | A3 | |
| AT247657T | Austria | T | |
| ATE247657T1 | Austria | T1 | |
| NO20034176D0 | Norway | D0 | |
| AR031528A1 | Argentina | A1 | |
| DE60004685D1 | Germany | D1 | |
| MXPA02002898A | Mexico | A | |
| KR20030088115A | Republic of Korea | A | |
| NO20034176L | Norway | L | |
| US6660744B1 | United States of America | B1 | |
| DK1212327T3 | Denmark | T3 | |
| ECSP034774A | Ecuador | A | |
| PL354249A1 | Poland | A1 | |
| PT1212327E | Portugal | E | |
| EP1385524A1 | European Patent Office (EPO) | A1 | |
| EP1212327B8 | European Patent Office (EPO) | B8 | |
| SI1212327T1 | Slovenia | T1 | |
| IL157642D0 | Israel | D0 | |
| CZ20032858A3 | Czechia | A3 | |
| ES2207552T3 | Spain | T3 | |
| NZ517758A | New Zealand | A | |
| MXPA03008561A | Mexico | A | |
| SK13082003A3 | Slovakia | A3 | |
| AR035790A1 | Argentina | A1 | |
| ZA200306886B | South Africa | B | |
| DE60004685T2 | Germany | T2 | |
| CN1520298A | China | A | |
| JP2004531513A | Japan | A | |
| HK1050355B | Hong Kong, China | B | |
| BR0205889A | Brazil | A | |
| PL363740A1 | Poland | A1 | |
| BG108269A | Bulgaria | A | |
| AU780052B2 | Australia | B2 | |
| TWI230709B | Taiwan Province of China | B | |
| US6921763B2 | United States of America | B2 | |
| CO5550444A2 | Colombia | A2 | |
| EP1385524A4 | European Patent Office (EPO) | A4 |
32 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)DPE2 | DPE2 | WO | |
| Wipo information: refused in national officeWWR | WWR | WO | |
| Wipo information: grant in national officeWWG | WWG | WO | |
| Wipo information: grant in national officeWWG | WWG | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: grant in national officeWWG | WWG | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Entry into the national phaseENP | ENP | BG | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Entry into the national phaseENP | ENP | JP | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Designated statesAK | AK | WO | |
| Designated countries for regional patentsAL | AL | WO | |
| Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)DFPE | DFPE | WO | |
| Ep: the epo has been informed by wipo that ep was designated in this application121 | 121 | WO | |
| Designated statesAK | AK | WO | |
| Designated countries for regional patentsAL | AL | WO |
Numbers
- Publication
- 01/19829
- Publication, DOCDB
- 0119829
- Publication, EPODOC
- WO0119829
- Application
- 25468
- Application, DOCDB
- 0025468
- Application, EPODOC
- WO2000US25468
Titles2
- English
- PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS
- French
- PYRAZOLOPYRIMIDINES EN TANT QU'AGENTS THERAPEUTIQUES
Classification
- CPC, 27
- C07D487/04
- C07F9/6561
- A61P1/04
- A61P1/16
- A61P11/00
- A61P11/06
- A61P13/00
- A61P13/12
- A61P15/16
- A61P17/02
- A61P17/06
- A61P19/02
- A61P25/00
- A61P27/02
- A61P29/00
- A61P31/04
- A61P31/22
- A61P33/02
- A61P35/00
- A61P35/02
- A61P37/06
- A61P43/00
- A61P5/14
- A61P7/06
- A61P9/00
- A61P9/10
- A61P3/10
- IPC, 30
- A61K31 519
- A61K31 5377
- A61K38 22
- A61P1 04
- A61P1 16
- A61P3 10
- A61P5 14
- A61P7 06
- A61P9 00
- A61P9 10
- A61P11 00
- A61P11 06
- A61P13 00
- A61P13 12
- A61P15 16
- A61P17 02
- A61P17 06
- A61P19 02
- A61P25 00
- A61P27 02
- A61P29 00
- A61P31 04
- A61P31 22
- A61P33 02
- A61P35 00
- A61P35 02
- A61P37 06
- A61P43 00
- C07D487 04
- C07F9 6561
Designated states111
- Regional, 58
- African Regional Intellectual Property Organization (ARIPO)
- Ghana
- Gambia
- Kenya
- Lesotho
- Malawi
- Mozambique
- Sudan
- Sierra Leone
- Eswatini
- United Republic of Tanzania
- Uganda
- Zimbabwe
- Eurasian Patent Organization (EAPO)
- Armenia
- Azerbaijan
- Belarus
- Kyrgyzstan
- Kazakhstan
- Republic of Moldova
- Russian Federation
- Tajikistan
- Turkmenistan
- European Patent Office (EPO)
and 34 moreShow fewer
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- African Intellectual Property Organization (OAPI)
- Burkina Faso
- Benin
- Central African Republic
- Congo
- Côte d’Ivoire
- Cameroon
- Gabon
- Guinea
- Guinea-Bissau
- Mali
- Mauritania
- Niger
- Senegal
- Chad
- Togo
- National, 53
- United Arab Emirates
- Antigua and Barbuda
- Albania
- Australia
- Bosnia and Herzegovina
- Barbados
- Bulgaria
- Brazil
- Belize
- Canada
- China
- Costa Rica
- Cuba
- Czechia
- Dominica
- Algeria
- Estonia
- Grenada
- Georgia
- Croatia
- Hungary
- Indonesia
- Israel
- India
and 29 moreShow fewer
- Iceland
- Japan
- Democratic People’s Republic of Korea
- Republic of Korea
- Saint Lucia
- Sri Lanka
- Liberia
- Lithuania
- Latvia
- Morocco
- Madagascar
- North Macedonia
- Mongolia
- Mexico
- Norway
- New Zealand
- Poland
- Romania
- Singapore
- Slovenia
- Slovakia
- Türkiye
- Trinidad and Tobago
- Ukraine
- United States of America
- Uzbekistan
- Viet Nam
- Yugoslavia, later Serbia and Montenegro (until 2006)
- South Africa